Zepbound vs Wegovy: How to Choose When Coverage Calls the Shots
7 min read
Choosing between Zepbound vs Wegovy looks like a contest over weight-loss numbers. In practice, your insurance plan and your health history often narrow the field first. Both are prescription medicines for adults, but they differ in active ingredient, form and labeled uses. Here is how to compare them, so you arrive at your prescriber's office and your insurer's phone line with the right questions.
Two drugs, two active ingredients
Wegovy contains semaglutide. Novo Nordisk's Wegovy page says it comes as an injection and as tablets. Wegovy is FDA-approved for chronic weight management in eligible patients. Certain Wegovy formulations also have additional FDA-approved uses, including reducing the risk of major cardiovascular events in eligible adults. Approved uses vary by formulation, so check the current FDA prescribing information. Both uses go with a reduced calorie diet and more physical activity.
Zepbound contains tirzepatide. Lilly's Zepbound site presents it as an injection for adults with obesity or obstructive sleep apnea (OSA), and says it can help you lose excess body weight and keep it off. GoodRx notes that Zepbound comes only as an injection, while Wegovy comes in both forms. The Advisory Board explains that tirzepatide acts on two hormones, GLP-1 and GIP, whereas semaglutide acts on GLP-1 alone.
What the Zepbound vs Wegovy trial reported
Lilly ran a direct comparison of its drug and Novo Nordisk's. Lilly's announcement of the trial reports average weight loss of 20.2% with Zepbound versus 13.7% with Wegovy. Lilly also says Zepbound was superior to Wegovy across the weight outcomes it reports. Maven Clinic cites the same 13.7% figure for Wegovy in its own comparison.
Read those numbers with care. Lilly makes Zepbound, and it published the result. An average describes a group, not you, so nobody can promise a specific outcome. Finally, the figures describe the branded drugs used as directed in the trial, which matters again in the compounding section below.
| Feature | Wegovy | Zepbound |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Forms | Injection and tablets | Injection only |
| Uses named by the makers | Weight loss and weight maintenance in adults; lower cardiovascular event risk in adults with known heart disease and obesity or overweight | Adults with obesity or obstructive sleep apnea |
| Average weight loss in Lilly's head-to-head trial | 13.7% | 20.2% |
Why your plan may choose for you
A higher average does not settle the question when your plan covers only one drug. Insurers publish formularies, which are lists of covered drugs, and a plan can list one weight-loss medicine and leave the other off. Many plans also require prior authorization, which means your prescriber submits paperwork before the plan agrees to pay. Employer plans can set their own rules too, so two people with the same insurer may get different answers.
Your diagnosis can steer the Zepbound vs Wegovy decision as well. Someone with sleep apnea and obesity may find Zepbound's OSA use relevant to a coverage request. Someone with known heart disease and obesity may find Wegovy's cardiovascular use relevant. Your prescriber decides what fits your health, while the plan's criteria decide what it pays for.
Pen or pill: how the form changes your routine
Form shapes your daily routine. Zepbound is an injection. Wegovy comes as an injection and as tablets, so someone who wants to avoid needles has an option with Wegovy that Zepbound does not offer. Novo Nordisk also warns that you should never share a Wegovy FlexTouch pen, even if the needle has changed, because sharing can pass on a serious infection. Tablets carry their own rules: Novo says breastfeeding is not recommended during treatment with Wegovy tablets. Your prescriber can explain how each form fits your life, and your plan may cover one form but not the other.
Questions to ask your insurer before you decide
One phone call can save weeks of back and forth. Ask these questions and write down the answers.
- Is Wegovy covered, and in which form: injection, tablets or both?
- Is Zepbound covered, and for which use: obesity, sleep apnea or both?
- Does either drug need prior authorization, and what records does the plan want?
- What will I pay, and does a deductible apply first?
- If the plan denies a request, what is the appeal process and its deadline?
Note the date and the representative's name each time. If the plan declines both drugs, ask your prescriber about manufacturer savings and self-pay programs, because their terms differ from insurance and change over time. Read those terms on the official pages before you rely on them.
Safety points that apply when you compare
Wegovy's safety information opens with a warning about possible thyroid tumors, including cancer. Novo Nordisk says not to use Wegovy if you or your family have had medullary thyroid carcinoma, or if you have Multiple Endocrine Neoplasia syndrome type 2. It also lists pancreatitis, gallbladder problems, dehydration that can harm the kidneys, and serious allergic reactions. The most common side effects include nausea, diarrhea, vomiting and constipation. Zepbound has its own safety information on its official site, so read it before your visit.
Novo Nordisk adds one firm rule: Wegovy should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines. That means the two drugs are not a stack. Moving from one to the other is a decision for your prescriber, who weighs your history, your dose and your plan's rules. Novo also says Wegovy may harm an unborn baby, so tell your prescriber if you are pregnant or plan to become pregnant.
Compounded versions are a different product
Compounded semaglutide and tirzepatide are not FDA-approved. They are not generic Wegovy or Zepbound, and they are not identical to the branded drugs. The 20.2% and 13.7% figures come from trials of the branded products, so they do not carry over to a compounded version. FDA and state rules on compounding change what pharmacies can sell, so ask your prescriber and your pharmacy what applies in your state.
Where to confirm current prices and terms
Cash prices and coupon terms for Zepbound vs Wegovy change often, so this guide quotes none. Start with the official Zepbound and Wegovy pages, and watch Novo Nordisk's US newsroom for company announcements. Look for every savings or coverage route each page lists. Costs and suitability vary from person to person, so a licensed clinician should confirm what applies to you.
Action Steps
- List your health facts: Write down your diagnoses, current medicines and any thyroid, pancreas, gallbladder or kidney history to share with your prescriber.
- Call your insurer: Ask whether Wegovy, Zepbound or both are covered, in which forms, and whether prior authorization applies.
- Match uses to your diagnosis: Ask your prescriber whether sleep apnea or cardiovascular disease affects which drug and which coverage request fit you.
- Decide on form: Discuss pen versus tablet with your prescriber and check whether your plan covers the form you prefer.
- Read official price terms: Check the maker pages for savings, self-pay and Medicare information before you rely on any cost estimate.
- Plan for a denial: Ask for the denial reason in writing and the appeal deadline, then work through the appeal with your prescriber.
Frequently Asked Questions
Is Zepbound or Wegovy better for weight loss?
In Lilly's head-to-head trial, average weight loss was 20.2% with Zepbound and 13.7% with Wegovy. An average does not predict your result, and your health history, side effects and coverage also matter. Your prescriber can help you decide what fits.
Can I take Zepbound and Wegovy together?
Novo Nordisk says Wegovy should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines. Ask your prescriber before any change involving either drug.
Does Zepbound come as a pill like Wegovy?
GoodRx reports that Zepbound is available only as an injection, while Wegovy comes as an injection and as tablets. Check the official pages for any change in available forms.
Are compounded versions the same as Zepbound or Wegovy?
No. Compounded semaglutide and tirzepatide are not FDA-approved, they are not generic versions of the branded drugs, and trial results for Wegovy or Zepbound do not apply to them.
What if my insurer denies coverage for one of them?
Ask for the denial reason and the appeal deadline, then talk with your prescriber about an appeal, the other drug, or manufacturer savings and self-pay programs. Confirm each program's terms on its official page.
